Eleanor Vierra
Acute Care · Sacramento, CANPI 1487726550
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $51,605 of the $63,844 with a category attached, or 80.8%. Johnson & Johnson accounts for 96.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $24,680 and has fallen 99.2% since, to $202 in 2025. Among acute care clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $769.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$62K
- Biotronik Inc.$746
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$349
- Boston Scientific$291
- Abbott$269
- Medtronic$170
- plus $401 from 5 others
What the payments were for
- Speaking & faculty fees$51,60581%
- Travel & lodging$9,44715%
- Food & beverage$2,7924%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 59 | $61,618 |
| Biotronik Inc. | 4 | $746 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $349 |
| Boston Scientific | 5 | $291 |
| Abbott | 3 | $269 |
| Medtronic | 1 | $170 |
| Irhythm Technologies, Inc. | 2 | $146 |
| Actelion Pharmaceuticals US, Inc. | 1 | $140 |
| Lexicon Pharmaceuticals, Inc. | 3 | $67 |
| Atricure, Inc. | 1 | $31 |
| Biosense Webster, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$61,008
- Acticor 7 VR-T DX$272
- LifeVest$263
- BioMonitor$229
- AURORA EV-ICD MRI SURESCAN$170
- UPTRAVI$140
- OPSUMIT$140
- ZIO XT Patch$131
- MitraClip$130
- Rivacor$124
- Edora$124
- Acticor$124
- Solia$124
- EMBLEM$123
- Edora 8 DR-T$105
How this compares
$63,844 in reported general payments places this provider in the 95th percentile of 1,153 acute care providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 71 | $75,378 |
| EntrestoSacubitril/Valsartan | 52 | $59,855 |
| MultaqDronedarone Hcl | 29 | $40,438 |
| XareltoRivaroxaban | 30 | $35,554 |
| JardianceEmpagliflozin | 14 | $9,460 |
| Digoxin | 32 | $3,775 |
| Amiodarone Hcl | 97 | $1,330 |
| Sotalol AfSotalol Hcl | 29 | $1,221 |
| Metoprolol Succinate | 61 | $1,217 |
| Flecainide Acetate | 43 | $1,159 |
| SotalolSotalol Hcl | 40 | $850 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 32 | $648 |
| Valsartan | 18 | $564 |
| Spironolactone | 47 | $373 |
| Bumetanide | 12 | $294 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $61,618 | $35,55430 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,153 acute care providers in California.
Other acute care in Sacramento
- Leslie PetersenCamarillo$370K
- Joyce KhremianSan Dimas$73K
- Frances DyLos Angeles$57K
- Savannah HarrisVentura$56K
- Kori Ann JohnstonLos Angeles$42K
- Caroline KwongOrange$42K
- Gregory KnutzenColton$41K
- Sunita BoparaiLos Angeles$37K
- Sherona BauLos Angeles$32K
- Samantha ShenoySan Francisco$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.